T 0314/20 of 16.11.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T031420.20231116
- Date of decision
- 16 November 2023
- Case number
- T 0314/20
- Petition for review of
- -
- Application number
- 08787264.4
- IPC class
- A61P 3/06A61P 3/04A61K 31/00A61K 9/48A61K 31/70A61K 9/20A61P 3/10A61K 9/14A61K 31/7034A61K 9/00A61K 9/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on Article 056 EPC
- Application title
- PHARMACEUTICAL COMPOSITION COMPRISING A GLUCOPYRANOSYL-SUBSTITUTED BENZENE DERIVATIVE
- Applicant name
- Boehringer Ingelheim International GmbH
- Opponent name
- Generics (U.K.) Limited
STADA Arzneimittel AG
Hexal AG
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 112(1)(a)European Patent Convention Art 56
- Keywords
- Inventive step - technical effect derivable from the application as originally filed in the sense of G 2/21, point 2 of the order (no)
Inventive step - obvious solution
Referral to the Enlarged Board of Appeal - (no) - Catchword
- On the interpretation of decision G 2/21 (see points 6.12 to 6.13.11 of the Reasons)
- Citing cases
- T 1385/23
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The request for referral of questions to the Enlarged Board of Appeal is refused.
3. The patent is revoked.